Restructuring and Impairment Activities

3 Months Ended

Mar. 31, 2021

Restructuring and Related Activities [Abstract]

The Company incurred restructuring and impairment expense of $1.7 million and $0.1 million in the three months ended March 31, 2021 and 2020, respectively, in the EP segment.

During the third quarter of 2020, we announced plans to shut down the Spotswood, New Jersey facility and shift the production of paper made there to other SWM facilities. This decision was part of our ongoing manufacturing optimization efforts and involved the co-development of a new paper production technology with one of the Company’s key customers. Production of paper at this facility ceased as of December 31, 2020.

As a result of this decision, $1.4 million of restructuring and impairment expense was recognized in the three months ended March 31, 2021 related to the costs associated with closing this facility, maintaining the property and preparing it for sale.

In addition to restructuring costs relating to the Spotswood facility, the EP segment recognized $0.3 million and $0.1 million for the three months ended March 31, 2021 and 2020, respectively, related to severance accruals for employees at other manufacturing facilities. These restructuring charges relate to ongoing cost optimization initiatives to remain competitive within the EP segment. The cost optimization initiative project started in 2019 and is expected to be completed in 2022. The EP segment has recognized $7.2 million of restructuring charges cumulatively through March 31, 2021 related to this project.

The Company expects to record additional restructuring related costs in the EP segment during 2021 of approximately $1.4 million relating to the shutdown of the Spotswood, New Jersey facility, primarily associated with closing the facility and maintaining the property until it is sold. The Company does not expect to incur significant restructuring expenses related to the cost optimization initiatives in the EP segment during the remainder of 2021.

In the AMS segment, there were no restructuring and impairment expenses for the three months ended March 31, 2021 and 2020.

The following table summarizes total restructuring and related charges for the three months ended March 31, 2021:


	Three Months Ended
	March 31, 2021		March 31, 2020
Restructuring and impairment expense:
Severance	$	0.3	$	0.1
Other	1.4		—
Total restructuring and impairment expense	$	1.7	$	0.1

The following table summarizes changes in restructuring liabilities during the periods ended March 31, 2021 and December 31, 2020. ($ in millions):


	Three Months Ended
	March 31, 2021		March 31, 2020
Balance at beginning of year	$	7.4	$	0.5
Accruals for announced programs	0.3		0.1
Cash payments	(2.2)		(0.3)
Foreign exchange impact	(0.1)		—
Balance at end of period	$	5.4	$	0.3

Restructuring liabilities were classified within Accrued expenses and other current liabilities in each of the condensed consolidated balance sheets.